Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Julie Ann Justo and Majdi Al-Hasan.
Connection Strength

8.320
  1. Direct Measurement of Performance: A New Era in Antimicrobial Stewardship. Antibiotics (Basel). 2019 Aug 24; 8(3).
    View in: PubMed
    Score: 0.694
  2. Ignoring the Elephant: Does the Infectious Diseases Society of America Support Sepsis-3 or Pre-sepsis Criteria? Clin Infect Dis. 2019 04 08; 68(8):1431.
    View in: PubMed
    Score: 0.676
  3. Duration of Antimicrobial Therapy for Enterobacteriaceae Bacteremia: Using Convenient End Points for Convenient Conclusions. Clin Infect Dis. 2018 06 01; 66(12):1978-1979.
    View in: PubMed
    Score: 0.637
  4. Impact of Penicillin Allergy on Empirical Carbapenem Use in Gram-Negative Bloodstream Infections: An Antimicrobial Stewardship Opportunity. Pharmacotherapy. 2018 01; 38(1):42-50.
    View in: PubMed
    Score: 0.617
  5. Combination therapy vs. monotherapy for Gram-negative bloodstream infection: matching by predicted prognosis. Int J Antimicrob Agents. 2018 Mar; 51(3):488-492.
    View in: PubMed
    Score: 0.607
  6. Show me the data: A statewide comparative report of National Healthcare Safety Network (NHSN) Antimicrobial Use Option standardized antimicrobial administration ratios (SAARs). Antimicrob Steward Healthc Epidemiol. 2022; 2(1):e119.
    View in: PubMed
    Score: 0.212
  7. Evaluation of early clinical failure criteria in Enterococcus species bloodstream infection. Infection. 2022 Aug; 50(4):873-877.
    View in: PubMed
    Score: 0.205
  8. Prediction of mortality in Staphylococcus aureus bloodstream infection using quick Pitt bacteremia score. J Infect. 2022 02; 84(2):131-135.
    View in: PubMed
    Score: 0.203
  9. Change in Antimicrobial Use During COVID-19 Pandemic in South Carolina Hospitals: A Multicenter Observational Cohort Study. Int J Antimicrob Agents. 2021 Dec; 58(6):106453.
    View in: PubMed
    Score: 0.201
  10. Impact of follow up blood cultures on outcomes of patients with community-onset gram-negative bloodstream infection. EClinicalMedicine. 2021 Apr; 34:100811.
    View in: PubMed
    Score: 0.194
  11. Application of Standardized Antimicrobial Administration Ratio as a Motivational Tool within a Multi-Hospital Healthcare System. Pharmacy (Basel). 2021 Feb 07; 9(1).
    View in: PubMed
    Score: 0.192
  12. Clostridioides difficile infection and antibiotic prescription rates in the community: Explaining the gender gap. Infect Control Hosp Epidemiol. 2021 05; 42(5):622-624.
    View in: PubMed
    Score: 0.189
  13. Temporal trends in ambulatory antibiotic prescription rates in South Carolina: Impact of age, gender, and resident location. Infect Control Hosp Epidemiol. 2020 08; 41(8):879-882.
    View in: PubMed
    Score: 0.183
  14. Multicenter, Observational Cohort Study Evaluating Third-Generation Cephalosporin Therapy for Bloodstream Infections Secondary to Enterobacter, Serratia, and Citrobacter Species. Antibiotics (Basel). 2020 May 14; 9(5).
    View in: PubMed
    Score: 0.182
  15. Impact of Reappraisal of Fluoroquinolone Minimum Inhibitory Concentration Susceptibility Breakpoints in Gram-Negative Bloodstream Isolates. Antibiotics (Basel). 2020 Apr 17; 9(4).
    View in: PubMed
    Score: 0.181
  16. Empirical fluoroquinolones versus broad-spectrum beta-lactams for Gram-negative bloodstream infections in the absence of antimicrobial resistance risk factors. J Glob Antimicrob Resist. 2020 09; 22:87-93.
    View in: PubMed
    Score: 0.178
  17. Burden of community-associated Clostridioides difficile infection in southeastern United States: a population-based study. Infection. 2020 Feb; 48(1):129-132.
    View in: PubMed
    Score: 0.176
  18. Role of Early De-escalation of Antimicrobial Therapy on Risk of Clostridioides difficile Infection Following Enterobacteriaceae Bloodstream Infections. Clin Infect Dis. 2019 07 18; 69(3):414-420.
    View in: PubMed
    Score: 0.172
  19. Syndrome-specific versus prospective audit and feedback interventions for reducing use of broad-spectrum antimicrobial agents. Am J Infect Control. 2019 11; 47(11):1284-1289.
    View in: PubMed
    Score: 0.171
  20. Seasonal variation in antimicrobial resistance rates of community-acquired Escherichia coli bloodstream isolates. Int J Antimicrob Agents. 2019 Jul; 54(1):1-7.
    View in: PubMed
    Score: 0.168
  21. Utility of Combination Antimicrobial Therapy in Adults with Bloodstream Infections due to Enterobacteriaceae and Non-Fermenting Gram-Negative Bacilli Based on In Vitro Analysis at Two Community Hospitals. Antibiotics (Basel). 2019 Feb 08; 8(1).
    View in: PubMed
    Score: 0.167
  22. Bloodstream Infection due to Piperacillin/Tazobactam Non-Susceptible, Cephalosporin-Susceptible Escherichia coli: A Missed Opportunity for De-Escalation of Therapy. Antibiotics (Basel). 2018 Dec 01; 7(4).
    View in: PubMed
    Score: 0.165
  23. Risk factors for pneumonia due to beta-lactam-susceptible and beta-lactam-resistant Pseudomonas aeruginosa: a case-case-control study. Infection. 2018 Aug; 46(4):487-494.
    View in: PubMed
    Score: 0.159
  24. Reply to comments: duration of antimicrobial therapy for Gram-negative bacteremia secondary to urinary source of infection. Infection. 2018 04; 46(2):283-284.
    View in: PubMed
    Score: 0.156
  25. Development of Institutional Guidelines for Management of Gram-Negative Bloodstream Infections: Incorporating Local Evidence. Hosp Pharm. 2017 Nov; 52(10):691-697.
    View in: PubMed
    Score: 0.150
  26. Optimal duration of antimicrobial therapy for uncomplicated Gram-negative bloodstream infections. Infection. 2017 Oct; 45(5):613-620.
    View in: PubMed
    Score: 0.148
  27. Application of Fluoroquinolone Resistance Score in Management of Complicated Urinary Tract Infections. Antimicrob Agents Chemother. 2017 05; 61(5).
    View in: PubMed
    Score: 0.148
  28. Clinical Risk Score for Prediction of Extended-Spectrum ?-Lactamase-Producing Enterobacteriaceae in Bloodstream Isolates. Infect Control Hosp Epidemiol. 2017 03; 38(3):266-272.
    View in: PubMed
    Score: 0.144
  29. Association between inappropriate empirical antimicrobial therapy and hospital length of stay in Gram-negative bloodstream infections: stratification by prognosis. J Antimicrob Chemother. 2017 01; 72(1):299-304.
    View in: PubMed
    Score: 0.142
  30. Differential effect of prior ?-lactams and fluoroquinolones on risk of bloodstream infections secondary to Pseudomonas aeruginosa. Diagn Microbiol Infect Dis. 2017 Jan; 87(1):87-91.
    View in: PubMed
    Score: 0.142
  31. Effectiveness of oral antibiotics for definitive therapy of Gram-negative bloodstream infections. Int J Antimicrob Agents. 2016 Nov; 48(5):498-503.
    View in: PubMed
    Score: 0.141
  32. Association between chronic hemodialysis and bloodstream infections caused by chromosomally mediated AmpC-producing Enterobacteriaceae. Am J Infect Control. 2016 12 01; 44(12):1611-1616.
    View in: PubMed
    Score: 0.140
  33. Prediction of Fluoroquinolone Resistance in Gram-Negative Bacteria Causing Bloodstream Infections. Antimicrob Agents Chemother. 2016 Apr; 60(4):2265-72.
    View in: PubMed
    Score: 0.137
  34. Epidemiology, Outcomes and Tolerability of Protracted Treatment of Nontuberculous Mycobacterial Infections at a Community Teaching Hospital in the Southeastern United States. Antibiotics (Basel). 2022 Nov 29; 11(12).
    View in: PubMed
    Score: 0.054
  35. Candida parapsilosis bloodstream infection in an immunocompromised host with discordant multiplex polymerase chain reaction and conventional blood culture results: a case report. Ther Adv Infect Dis. 2022 Jan-Dec; 9:20499361221138446.
    View in: PubMed
    Score: 0.054
  36. Clinical Utility and Cost Effectiveness of Long-Acting Lipoglycopeptides Used in Deep-Seated Infections among Patients with Social and Economic Barriers to Care. Pharmacy (Basel). 2021 Dec 23; 10(1).
    View in: PubMed
    Score: 0.051
  37. Evaluating appropriateness and diagnostic stewardship opportunities of multiplex polymerase chain reaction gastrointestinal testing within a hospital system. Ther Adv Infect Dis. 2020 Jan-Dec; 7:2049936120959561.
    View in: PubMed
    Score: 0.047
  38. Regional and statewide antibiograms as targeted interventions against antibiotic resistance. Infect Control Hosp Epidemiol. 2021 04; 42(4):503-505.
    View in: PubMed
    Score: 0.046
  39. Pharmacist-Driven Culture and Sexually Transmitted Infection Testing Follow-Up Program in the Emergency Department. Pharmacy (Basel). 2020 Apr 23; 8(2).
    View in: PubMed
    Score: 0.045
  40. Prediction of trimethoprim/sulfamethoxazole resistance in community-onset urinary tract infections. J Glob Antimicrob Resist. 2020 06; 21:218-222.
    View in: PubMed
    Score: 0.044
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.